Keyphrases
Anticancer Activity
9%
Anticancer Agents
9%
Anticancer Effect
9%
Anticancer Therapeutics
9%
Apoptosis
27%
Breast Cancer
9%
Breast Cancer Cell Lines
9%
Breast Cancer Subtypes
9%
Brevilin A
100%
Cancer Effects
9%
Cancer Therapeutic Drug
9%
Cell Cycle Arrest
18%
Cell Migration
9%
Cell Viability
9%
Estrogen Receptor
9%
Flow Cytometry
9%
High Efficacy
9%
Human Epidermal Growth Factor Receptor 2 (HER2)
9%
Inhibitory Effect
9%
M Phase Arrest
9%
Mammalian Target of Rapamycin (mTOR)
18%
MTT Assay
9%
Oral Administration
9%
Orthotopic Tumor Xenograft
9%
Phosphorylation
9%
PI3K-AKT-mTOR Pathway
100%
Poor Prognosis
9%
Progesterone Receptor
9%
Protein Expression
9%
Sesquiterpene Lactones
100%
Signaling Pathway
9%
STAT3 Signaling Pathway
100%
Triple-negative Breast Cancer
36%
Triple-negative Breast Cancer Cells
100%
Tumor Cell Migration
9%
Tumor Inhibition
9%
Tumor Proliferation
9%
Tumor Xenograft Model
9%
Western Blot Analysis
9%
Wound Healing Assay
9%
Xenograft Mice
9%
Xenograft Mouse Model
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
12%
Breast Cancer
25%
Cell Viability
12%
Estrogen Receptor
12%
Flow Cytometry
12%
Malignant Neoplasm
37%
Mouse Model
25%
Neoplasm
37%
Progesterone Receptor
12%
Receptor
12%
Sesquiterpene Lactone
100%
STAT3 Protein
25%
Triple Negative Breast Cancer
100%
Tumor Growth
25%
Western Blot
12%
Wound Healing
12%